The development of the in vitro diagnostic industry in China began in the 1980s. After more than 20 years of development, it now has the conditions for industrial scale development. By the end of 2009, the users of IVD products in China mainly included 20,291 hospitals, 27,308 community health service centers (stations), 39,627 township hospitals, 526 blood stations, more than 6,000 medical examination centers, 3,536 CDCs, and industry research. Corporate institutions and emerging clinical laboratory independent laboratories.
With the rapid development of our country's economy, the nation's policy of benefiting the people and the reform of the medical system have continuously increased people's awareness of health. The ever-increasing population and aging population are increasingly pressing for the demand for medical instruments. At present, China is the seventh largest IVD market in the world, with a market size of 15 billion yuan in 2010. China's per capita annual IVD expenditure is less than US$2, while mature markets each have an annual expenditure of US$28. The gap is very different. However, overall, the development potential of the in vitro diagnostic industry in China is huge.
In recent years, medical device products have gradually extended to multi-functions, product structure has been continuously adjusted, and the market has expanded. According to industry experts, the compound annual growth rate of the market scale of the in vitro diagnostic industry in 2006-2012 is expected to reach 15%, showing a trend of rapid growth. .
From the perspective of the global market, the IVD of mature markets in developed countries has reached a relatively stable stage. The future growth of European countries and the United States is expected to be around 5-6%, and its momentum is showing a steady slowdown. Japan's growth rate is only 2%. The ROW countries expect the future growth rate to reach 10% (source: McEvoy & Farmer). Experts predict that in the next few years, the market for clinical chemistry and immunochemistry will be the two largest markets. The compound growth rates of the two are 4.5% and 4.7% respectively; the genetic testing market will be the fastest growing among them. The compound growth rate is 6.7%, and the output value will exceed one billion US dollars.
The medical device industry is a multidisciplinary, knowledge-intensive and capital-intensive high-tech industry. The high-tech medical equipment in our country is increasing at a rate of about 14% per year. The huge market space, the demand for upgrading and the ever-increasing demand for medical services will drive the market and make medical equipment in China grow rapidly. According to the results of the in vitro diagnostic industry research, the average growth rate of sales of major companies in the industry in the past three years exceeded 20%. Industry experts analyze that in the past few years, China's IVD has maintained a growth rate of around 15%. In the future, IVD is expected to maintain a high growth rate of 15%, which is the fastest growing market in the world.
The demand for in-vitro diagnostic technology in China is developing toward polarization: a highly integrated and automated instrument diagnostic technology that combines highly efficient instrumentation, modular assembly, and streamlined automation to greatly improve diagnostic testing. Work efficiency; the other is a simple, rapid and easy to spread and on-site diagnostic testing techniques, requiring the miniaturization of experimental instruments, ease of operation, results of timely and accurate reports, increasingly favored by clinical staff.
Through research, it has been proved that the market share of early clinical chemical diagnosis in the in vitro diagnostic industry is the largest, but in recent years immunological diagnosis has gradually exceeded the share of clinical chemical diagnosis, and molecular diagnostics, as a newly emerging technology, has developed the fastest among all diagnostic types. With the deepening of human genome research, the research field of molecular diagnosis has been greatly expanded, and the development of laboratory medicine in disease diagnosis and evaluation of prognosis has been promoted.
With the rapid development of our country's economy, the nation's policy of benefiting the people and the reform of the medical system have continuously increased people's awareness of health. The ever-increasing population and aging population are increasingly pressing for the demand for medical instruments. At present, China is the seventh largest IVD market in the world, with a market size of 15 billion yuan in 2010. China's per capita annual IVD expenditure is less than US$2, while mature markets each have an annual expenditure of US$28. The gap is very different. However, overall, the development potential of the in vitro diagnostic industry in China is huge.
In recent years, medical device products have gradually extended to multi-functions, product structure has been continuously adjusted, and the market has expanded. According to industry experts, the compound annual growth rate of the market scale of the in vitro diagnostic industry in 2006-2012 is expected to reach 15%, showing a trend of rapid growth. .
From the perspective of the global market, the IVD of mature markets in developed countries has reached a relatively stable stage. The future growth of European countries and the United States is expected to be around 5-6%, and its momentum is showing a steady slowdown. Japan's growth rate is only 2%. The ROW countries expect the future growth rate to reach 10% (source: McEvoy & Farmer). Experts predict that in the next few years, the market for clinical chemistry and immunochemistry will be the two largest markets. The compound growth rates of the two are 4.5% and 4.7% respectively; the genetic testing market will be the fastest growing among them. The compound growth rate is 6.7%, and the output value will exceed one billion US dollars.
The medical device industry is a multidisciplinary, knowledge-intensive and capital-intensive high-tech industry. The high-tech medical equipment in our country is increasing at a rate of about 14% per year. The huge market space, the demand for upgrading and the ever-increasing demand for medical services will drive the market and make medical equipment in China grow rapidly. According to the results of the in vitro diagnostic industry research, the average growth rate of sales of major companies in the industry in the past three years exceeded 20%. Industry experts analyze that in the past few years, China's IVD has maintained a growth rate of around 15%. In the future, IVD is expected to maintain a high growth rate of 15%, which is the fastest growing market in the world.
The demand for in-vitro diagnostic technology in China is developing toward polarization: a highly integrated and automated instrument diagnostic technology that combines highly efficient instrumentation, modular assembly, and streamlined automation to greatly improve diagnostic testing. Work efficiency; the other is a simple, rapid and easy to spread and on-site diagnostic testing techniques, requiring the miniaturization of experimental instruments, ease of operation, results of timely and accurate reports, increasingly favored by clinical staff.
Through research, it has been proved that the market share of early clinical chemical diagnosis in the in vitro diagnostic industry is the largest, but in recent years immunological diagnosis has gradually exceeded the share of clinical chemical diagnosis, and molecular diagnostics, as a newly emerging technology, has developed the fastest among all diagnostic types. With the deepening of human genome research, the research field of molecular diagnosis has been greatly expanded, and the development of laboratory medicine in disease diagnosis and evaluation of prognosis has been promoted.
Survival kits,High Quality Survival kits,Survival kits Details, CN
Dongguan City Risen Medical Products Co., Ltd. , https://www.risenppe.com